Cantourage Group Future Growth

Future criteria checks 5/6

Cantourage Group is forecast to grow earnings and revenue by 112.7% and 38.6% per annum respectively. EPS is expected to grow by 1.8% per annum. Return on equity is forecast to be 6.5% in 3 years.

Key information

112.7%

Earnings growth rate

1.8%

EPS growth rate

Pharmaceuticals earnings growth21.5%
Revenue growth rate38.6%
Future return on equity6.5%
Analyst coverage

Low

Last updated19 Nov 2024

Recent future growth updates

Recent updates

Calculating The Intrinsic Value Of Cantourage Group SE (ETR:HIGH)

Jan 05
Calculating The Intrinsic Value Of Cantourage Group SE (ETR:HIGH)

Earnings and Revenue Growth Forecasts

XTRA:HIGH - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20268344N/A2
12/31/20256011N/A2
12/31/202443-10N/A2
6/30/202420N/AN/AN/A
3/31/202420N/AN/AN/A
12/31/202320N/AN/AN/A
9/30/202310N/AN/AN/A
6/30/202310N/AN/AN/A
12/31/202210N/AN/AN/A
12/31/20215-1N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: HIGH's forecast earnings growth (112.7% per year) is above the savings rate (1%).

Earnings vs Market: HIGH's earnings (112.7% per year) are forecast to grow faster than the German market (21% per year).

High Growth Earnings: HIGH's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: HIGH's revenue (38.6% per year) is forecast to grow faster than the German market (5.6% per year).

High Growth Revenue: HIGH's revenue (38.6% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: HIGH's Return on Equity is forecast to be low in 3 years time (6.5%).


Discover growth companies